MedTrace Logo

5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer

NCT06961955 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2025-12-09

No results posted yet for this study

Summary

The goal of this study is to evaluate 5 days vs. 9 days of whole breast radiation.

Conditions

  • Breast Cancer
  • Invasive Carcinoma of Breast
  • Ductal Breast Carcinoma in Situ

Interventions

RADIATION

Radiation Therapy

Undergo hypofractionated radiation therapy

Sponsors & Collaborators

Principal Investigators

  • Matthew R. Poppe, MD · Huntsman Cancer Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-21
Primary Completion
2030-05-31
Completion
2033-05-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06961955 on ClinicalTrials.gov